Clicky

Evotec Ag(EVOTF)

Description: Evotec AG provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company operates through two segments, EVT Execute and EVT Innovate. It offers drug discovery services, such as integrated services, target identification and validation, hit identification, compound management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, cell and protein production, and in vivo and in vitro pharmacology services, as well as absorption, distribution, metabolism, excretion, and toxicity services. The company is also involved in investing and developing proprietary assets, including early-stage discovery programs, as well as advanced drug candidates in the areas of diabetes and diabetic complications, inflammatory diseases, neuroscience, oncology, and pain and anti-infective. It has a drug discovery and development partnerships with Celgene Corporation; Novo Nordisk A/S; Sanofi; Almirall, S.A.; Ferring Pharmaceuticals; Centogene AG; Immuneering Corporation; and LEO Pharma A/S. Evotec AG was founded in 1993 and is headquartered in Hamburg, Germany.


Keywords: Biotechnology Life Sciences Pain Diabetes Pharmacology Drug Discovery Partnership Neuroscience Inflammatory Diseases Metabolism Pharmacokinetics Informatics Proteomics Hamburg Pharmaceutical And Biotech Drug Metabolism Drug Discovery Services Evotec City Services Pharmaceutical And Biotechnology Almirall Development Solution Compound Management Diabetic Complications Kinetics Metabolomics

Home Page: www.evotec.com

Essener Bogen 7
Hamburg, 22419
Germany
Phone: 49 40 560 81 0


Officers

Name Title
Dr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D. Chairman of Management Board & CEO
Mr. Enno Spillner CFO & Member of Management Board
Dr. Cord Dohrmann Ph.D. Chief Scientific Officer & Member of Management Board
Dr. Craig Johnstone COO & Member of Management Board
Dr. Matthias Evers Chief Bus. Officer & Member of Management Board
Ms. Anja Bosler Principal Accounting Officer and Sr. VP of Group Accounting
Mr. Volker Braun Sr. VP and Global Head of Investor Relations & ESG
Dr. Christian Dargel EVP Global Head of Legal & Compliance
Gabriele Hansen Sr. VP & Head of Global Corp. Communications & Marketing
Ms. Monika Conradt Global Head of HR

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 79.3651
Trailing PE: 417.1867
Price-to-Book MRQ: 2.2768
Price-to-Sales TTM: 4.3538
IPO Date:
Fiscal Year End: December
Full Time Employees: 4715
Back to stocks